Furthermore, DC vaccination and adoptive transfer of WT1-specific cytotoxic T cells showed to be auspicious therapeutic options in combination with allogeneic stem cell transplantation in AML patients [121,122]. This evidence concerns the gene WT1 and acute myeloid leukemia.